Christopher Puccio, CPA, currently serves as the Director of SEC Reporting & Accounting Policy at Mallinckrodt Pharmaceuticals since April 2024. Prior to this role, Christopher held various positions at Quaker Houghton, including Manager of Financial Reporting and Technical Accounting, where responsibilities included overseeing SEC filings, establishing a centralized Financial Reporting Department, and integrating acquisitions into accounting processes. Christopher also served as a Senior Financial Reporting Analyst at Neuronetics, Inc., contributing to S-1 and S-3 SEC filings and communicating key accounting judgments. Christopher began career at PwC as a Senior Associate in Assurance and has educational credentials from Saint Joseph's University, holding a Bachelor of Business Administration in Accounting.
April, 2024 - present